Comparative effectiveness and safety of the JAK inhibitors and biologic disease-modifying antirheumatic drugs in treating children with nonsystemic juvenile idiopathic arthritis: A Bayesian meta-analysis of randomized controlled trials.

Citation

Li Y, Huang B, Andorf S, Yue X, Lovell DJ, Brunner HI. Comparative effectiveness and safety of the JAK inhibitors and biologic disease-modifying antirheumatic drugs in treating children with nonsystemic juvenile idiopathic arthritis: A Bayesian meta-analysis of randomized controlled trials. ACR Open Rheumatol. 2025 Feb;7(2):e11788. doi: 10.1002/acr2.11788. PMID: 39964338; PMCID: PMC11834587.

Link

https://pubmed.ncbi.nlm.nih.gov/39964338/

Principal Investigator

Morgan, Esi M.

Huang, Bin

Project Name

Inform Shared Decision Making with Advanced Bayesian Causal Inference to Improve Quality of Pediatric Rheumatology Care

Technology

Database

Population

Children

Clinical Staff/Clinician